(19)
(11) EP 4 188 447 A1

(12)

(43) Date of publication:
07.06.2023 Bulletin 2023/23

(21) Application number: 20947059.0

(22) Date of filing: 29.07.2020
(51) International Patent Classification (IPC): 
A61K 47/50(2017.01)
A61K 47/54(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/55; C07D 471/04; C07D 519/00
(86) International application number:
PCT/US2020/044043
(87) International publication number:
WO 2022/025880 (03.02.2022 Gazette 2022/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: Foghorn Therapeutics Inc.
Cambridge MA 02142 (US)

(72) Inventors:
  • RUPPEL, Sabine, K.
    Cambridge, MA 02142 (US)
  • YANG, Zhaoxia
    Cambridge, MA 02142 (US)
  • LOWE, Jason, T.
    Cambridge, MA 02142 (US)
  • VOIGT, Johannes, H.
    Cambridge, MA 02142 (US)
  • NETHERTON, Matthew
    Cambridge, MA 02142 (US)
  • BRUCELLE, Francois
    Cambridge, MA 02142 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) COMPOUNDS AND USES THEREOF